Search for: "Eli Lilly " Results 681 - 700 of 2,131
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 May 2015, 4:00 am by Administrator
Eli Lily and Company, 2015 ONCA 305 [55] This is not a bilateral context where Apotex is the only party that has been wronged by Lilly. [read post]
1 May 2015, 12:35 pm by Dr. Shezad Malik
Actos Bladder Cancer Lawsuits Continue to Increase There are more than 4,000 federal personal injury, product liability lawsuits pending against Takeda Pharmaceuticals and Eli Lilly. [read post]
29 Apr 2015, 11:15 am
Indianapolis, Indiana - An Indiana patent lawyer for Eli Lilly and Company of Indianapolis, Indiana; Daiichi Sankyo Co., Ltd. of Tokyo, Japan; Daiichi Sankyo, Inc. of Parsippany, New Jersey; and Ube Industries, Ltd of Yamaguchi, Japan (collectively "Lilly") sued in the Southern District of Indiana alleging that Lupin Ltd. of Mumbai, India and Lupin Pharmaceuticals, Inc. of Baltimore, Maryland infringed Patent Nos. 8,569,325, titled Method of Treatment with… [read post]
29 Apr 2015, 6:35 am by Dr. Shezad Malik
Actos Bladder Cancer Lawsuits Continue to Increase There are more than 4,000 federal personal injury, product liability lawsuits pending against Takeda Pharmaceuticals and Eli Lilly. [read post]
26 Apr 2015, 6:14 pm
As an example if one considers how inventive step was assessed in Teva UK Limited & Teva Pharmaceuticals Limited v Leo Pharma A/S & Leo Laboratories Limited [2014] EWHC 3096 (Pat) (see Katpost here) one sees that for a pharmaceutical formulation the following criteria may be relevant:* obvious to try * reasonable expectation of success * prejudice * inventive selection * the Technograph test (Technograph v Mills & Rockley [1972] RPC 346) * synergyMr Justice Birss… [read post]
22 Apr 2015, 12:22 pm by Bloomberg
Four residents of the town of Princeton sued to revoke the school’s tax exemption, in part because it shares royalties with faculty, mostly from a patent that Eli Lilly & Co. turned into the cancer drug Alimta. [read post]
19 Apr 2015, 4:01 pm
 This year's version, subtitled "Maximising pharmaceutical patent lifecycles to foster innovation and growth", takes place at The Hotel Excelsior, Munich, from 22 to 23 June and is followed by a Masterclass on 24 June on how to draft solid pharma patent claims in light of the CJEU's rulings in Neurim, Medeva, Georgetown, Eli Lilly and Actavis v Sanofi. [read post]
10 Apr 2015, 3:00 am by Steve Brachmann
The early months of 2015 have been interesting ones for the pharmaceutical industry, an incredibly valuable industry sector that comes under our focus from time to time here at IPWatchdog. [read post]
10 Apr 2015, 3:00 am by Steve Brachmann
The early months of 2015 have been interesting ones for the pharmaceutical industry, an incredibly valuable industry sector that comes under our focus from time to time here at IPWatchdog. [read post]
10 Apr 2015, 3:00 am by Steve Brachmann
The early months of 2015 have been interesting ones for the pharmaceutical industry, an incredibly valuable industry sector that comes under our focus from time to time here at IPWatchdog. [read post]
10 Apr 2015, 3:00 am by Steve Brachmann
The early months of 2015 have been interesting ones for the pharmaceutical industry, an incredibly valuable industry sector that comes under our focus from time to time here at IPWatchdog. [read post]
3 Apr 2015, 7:01 am by Dr. Shezad Malik
Actos Bladder Cancer Lawsuits Continue to Increase There are more than 4,000 federal personal injury, product liability lawsuits pending against Takeda Pharmaceuticals and Eli Lilly. [read post]
2 Apr 2015, 7:51 am by Robert Kraft
” The Wall Street Journal added that Eli Lilly gained the rights to Cyramza when it acquired ImClone Systems in 2008. [read post]
29 Mar 2015, 9:00 pm by Marci A. Hamilton
Many other businesses, like Gen Con and Eli Lilly have negatively responded to the Indiana RFRA. [read post]
29 Mar 2015, 8:53 am by Dennis Crouch
  Although canceled IP has never been considered to provide rights, Eli Lilly assumes it has rights. [read post]
20 Mar 2015, 7:49 am by Dr. Shezad Malik
Actos Bladder Cancer Lawsuits Continue to Increase There are more than 4,000 Actos product liability and personal injury lawsuits against Takeda Pharmaceuticals and Eli Lilly, winding their way through the federal court system. [read post]
6 Mar 2015, 8:31 pm by Lawrence B. Ebert
Reuters reported on March 6:--Eli Lilly has lost a patent case in Germany over its blockbuster Alimta lung cancer drug to generic producer Actavis, hitting the U.S. drugmaker's future sales hopes for the medicine [read post]